Clinical Research Directory
Browse clinical research sites, groups, and studies.
IMPACT-HTN Study of Patients With Hypertension
Sponsor: Vivek Bhalla
Summary
An estimated 120 million people have high blood pressure (hypertension) in the US, of which approximately 10% have resistant hypertension. This study aims to enroll patients who continue to have hypertension while being treated with at least two medications. The study will follow patients for approximately 3 months and collect real-world information on changes in their health to identify an ideal patient profile that would benefit from 4th-line antihypertensive therapies, including, but not limited to, FDA-approved aprocitentan, renal denervation, mineralocorticoid receptor antagonists, etc.
Official title: Prospective Early Patient Experience Initiative (IMPACT-HTN)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-07-01
Completion Date
2027-04-01
Last Updated
2026-06-29
Healthy Volunteers
No
Locations (2)
Stanford University Hypertension Center
Palo Alto, California, United States
Duke University Hospital
Durham, North Carolina, United States